Most large employers hold steady on GLP-1 coverage, for now

By Allison Bell

News June 23, 2026 at 03:46 PM

Share & Print

What You Need To Know

WTW surveyed 294 clients with 2.8 million plan enrollees.
About 66% cover use of GLP-1 agonists to treat obesity.
Only 12% of the WTW clients that cover GLP-1 for obesity are likely or very likely to drop that benefit.

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.